DM DISEASE-A-MONTH is a leading monthly journal published by MOSBY-ELSEVIER, dedicated to disseminating pivotal research and insights across the spectrum of general medicine. With a history spanning from 1954 to 2024, this journal has established itself as a key resource within the field, reflecting its commitment to advancing medical knowledge and practice. As evidenced by its impressive Scopus ranking—currently at #79 out of 636 in General Medicine and falling within the 87th percentile—this journal occupies a prominent position in the medical literature landscape. Although not an open-access publication, DM DISEASE-A-MONTH continues to serve a diverse audience of researchers, healthcare professionals, and medical students, providing valuable updates on recent advances in medicine and enabling its readers to stay informed about emerging trends and critical health issues. Its current Q2 category ranking in the 2023 Medical (miscellaneous) field further underscores its relevance and impact, making it an essential addition to the library of any medical practitioner or researcher.

Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.

Egyptian Journal of Neurology Psychiatry and Neurosurgery, published by Springer, is a premier open-access journal that has been dedicated to advancing the fields of neurology, psychiatry, and neurosurgery since its inception in 2009. With an E-ISSN of 1687-8329, this journal aims to provide a dynamic platform for researchers and clinicians to disseminate their findings, fostering a rich dialogue on the latest developments and innovations within these critical disciplines. With an impactful open-access model adopted since 2018, the journal attracts a global audience, facilitating the exchange of knowledge and ideas across various medical and scientific landscapes. In the 2023 rankings, it holds impressive positions within the Q3 category for Neurology (clinical), Psychiatry and Mental Health, and Surgery, as well as Q4 in Miscellaneous Neuroscience, highlighting its value within the field. As a valuable resource for both budding scholars and seasoned professionals, the Egyptian Journal of Neurology Psychiatry and Neurosurgery offers insights that drive progress in the treatment and understanding of neurological and psychiatric conditions.

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE is a prominent scientific journal focusing on the fields of neurology and neurosurgery, published by the esteemed Czech Medical Society. Since its inception in 1973, the journal has aimed to disseminate significant research and advancements in clinical neurology and surgery, contributing to the body of knowledge for professionals and researchers in these fields. Operating under a non-open access model, it maintains a dedicated readership interested in valuable insights from the latest studies and clinical practices. The journal is currently classified in the Q4 category in both Neurology (Clinical) and Surgery, reflecting its ongoing efforts to provide a platform for impactful research, despite being ranked in the lower percentiles within Scopus. Based in Prague, Czech Republic, this journal not only serves as a repository of clinical findings but also encourages collaboration and scholarly dialogue among neurologists and neurosurgeons, driving the field towards further innovations in patient care. With coverage extending from 1973 to 2024, it stands as a key resource for those committed to advancing neurological and surgical sciences.

Expert Review of Vaccines, published by Taylor & Francis Ltd, is a pivotal open access journal that has established itself as a leading source of peer-reviewed articles focusing on vaccine research, development, and policy. With an impressive categorization in the top quartile (Q1) across various domains including Drug Discovery, Immunology, Molecular Medicine, and Pharmacology for 2023, this journal plays a crucial role in disseminating high-quality scientific findings that drive advances in the field. Located in the United Kingdom, it serves a global audience of researchers, healthcare professionals, and students seeking to stay abreast of cutting-edge developments in vaccination strategies and technologies. The journal’s Scopus ranks further attest to its excellence, boasting remarkable placements in Pharmacology and Drug Discovery, reflecting its impact and reach. Since transitioning to an open access format in 2023, the journal has enhanced accessibility to vital research, empowering a broader audience to contribute to and engage with the discourse surrounding vaccines. As the field of immunization continues to evolve, Expert Review of Vaccines remains a cornerstone for those committed to advancing knowledge and practice in this essential area of health science.

Canadian Journal of Neurological Sciences, published by Cambridge University Press, stands as a reputable source of knowledge in the field of neurology, dedicated to advancing research and clinical practice. With an ISSN of 0317-1671 and an E-ISSN of 2057-0155, this journal has been a cornerstone for the exchange of ideas since its inception in 1974 and will continue to cater to the academic community until 2024. Recognized in the top quartile (Q2) in various categories including Medicine (miscellaneous) and Neurology (clinical), its articles engage a broad audience, ranging from established researchers to students seeking to deepen their understanding of neurological sciences. Although the journal is not an open-access publication, it provides vital insights and research findings that contribute significantly to its fields. With a Scopus rank of #183 in clinical neurology and a percentile ranking that reflects its commendable standing, the Canadian Journal of Neurological Sciences is indispensable for those committed to the exploration and treatment of neurological disorders.

The Journal of Epidemiology and Global Health (ISSN: 2210-6006; E-ISSN: 2210-6014), published by SpringerNature, stands as a premier open-access platform in the field of epidemiology, dedicated to advancing our understanding of global health challenges since 2011. Based in Switzerland, this journal is recognized for its significant contributions to the discipline, achieving an impressive Q1 ranking in Epidemiology and positioning itself at the 88th percentile within the Scopus Medicine - Epidemiology category. With a goal to disseminate innovative research and foster dialogue among scholars, public health professionals, and students, the journal provides a rich repository of empirical studies, reviews, and theoretical contributions that address pressing epidemiological issues. Its commitment to open access ensures that vital research is freely available to the global community, thereby amplifying its impact and relevance. Researchers seeking to publish and access high-quality, peer-reviewed articles will find the Journal of Epidemiology and Global Health an invaluable resource in navigating the ever-evolving landscape of public health.

Future Neurology, published by Future Medicine Ltd, is an emerging peer-reviewed journal dedicated to the rapidly evolving field of neurology, with a keen focus on both clinical and translational research. Since its inception in 2007, the journal has provided a unique platform for sharing innovative findings and fostering collaboration among neurologists, neuroscientists, and healthcare professionals. Although currently categorized in the Q4 quartile for both Neurology and Clinical Neurology, Future Neurology strives to improve its impact factor by publishing high-quality research and reviews that address pressing issues in neurological health. With its commitment to disseminating knowledge, the journal serves as an essential resource for professionals and researchers seeking to stay informed about advancements in neurological science. It is particularly valuable for those looking to contribute to and engage with the latest developments in neurotherapeutics, diagnostics, and patient care strategies. The journal is indexed in major databases and is available in print and online formats, ensuring wider accessibility to its content for all stakeholders in the field.

ACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.

Zeitschrift für Neuropsychologie, published by HOGREFE AG in Switzerland, stands as a vital resource for scholars and practitioners in the fields of neuropsychology, cognitive neuroscience, and psychiatry. With an ISSN of 1016-264X and E-ISSN 1664-2902, this journal aims to disseminate high-quality research that enhances understanding of cognitive processes and their implications for mental health. While currently classified in the fourth quartile across relevant categories, including Cognitive Neuroscience and Neuropsychology, it offers valuable insights that contribute to the emerging discourse in these areas. By publishing both empirical studies and theoretical papers, it encourages interdisciplinary dialogues among researchers and clinicians. Although the journal is not Open Access, its role in advancing neuropsychological research is significant, fostering academic linkages from its base in Bern, Switzerland. By continually focusing on the latest advancements and fostering innovative approaches within the field, Zeitschrift für Neuropsychologie remains a crucial platform for those committed to exploring the complexities of the human mind.